EFEMP1 and liver cancer: Although these reports seemingly contradict our results that serum Fibulin-3 levels are associated with a significantly greater incidence of liver cancer (Supplemental Figure S3A, http://links.lww.com/HC9/A893, Supplemental Figure S4A, http://links.lww.com/HC9/A893), we focused on Fibulin-3 before the development of liver cancer and others focused on Fibulin-3 in liver cancer.